Israeli Covid Drug Hailed By Scientists As ‘Huge Breakthrough’

Israeli Covid Drug Hailed By Scientists As 'Huge Breakthrough' image: Pixabay

Israeli Covid Drug That Cured 30 Cases Of Disease Being Hailed By Scientists As ‘Huge Breakthrough’.

A new treatment for coronavirus, developed at Tel Aviv’s Ichilov Medical Center has completed the phase 1 trials. As per the reports by the hospital, it has also helped various serious cases of the virus. Terming it as a ‘huge breakthrough’, the hospital revealed that the EXO-CD24 substance had been administered to 30 patients whose conditions were moderate or worse. All of these patients have since recovered- 29 of them recovered within five days.

The Israeli government, recently, announced the extension of the COVID-19 lockdown in the country until February 7. Prime Minister Benjamin Netanyahu’s cabinet approved the restrictions to be extended until Sunday. The current lockdown measures were imposed in the country on December 27 following a surge in COVID-19 cases. Last month, the Israeli government extended the lockdown until February 5.

Prime Minister Netanyahu urged the members of the public to “strictly” follow the measures put in place to prevent the spread of the virus. He also called on people to get vaccinated as quickly as possible in order to be able to gradually start reopening the economy, claiming “the vaccines work”.

The country will witness gradual ease in restrictions starting February 7, which includes cancellation of the restrictions on movement, reopening of nature reserves, national parks, heritage sites, etc. Places of work, which do not receive public attention will also be allowed to reopen. Lodging facilities have been allowed to reopen from Sunday onwards, but only for small families, that include a couple and their children.

 


Thank you for taking the time to read this news article “Israeli Covid Drug Hailed By Scientists As ‘Huge Breakthrough’”. For more UK daily news, Spanish daily news and Global news stories, visit the Euro Weekly News home page.

FacebookTwitterRedditWhatsAppTelegramLinkedInEmailCopy Link
Go Back
Written by

Tony Winterburn

Share your story with us by emailing [email protected], by calling +34 951 38 61 61 or by messaging our Facebook page www.facebook.com/EuroWeeklyNews

Comments


    Leave a comment

    Your email address will not be published.